Alisha Charlton - Pro Dex CFO Secretary

PDEX Stock  USD 49.00  2.25  4.81%   

CFO

Ms. Alisha K. Charlton is Chief Financial Officer of the Company. She joined the Company in January 2014 as Senior Director of Finance. Prior to joining the Company, Ms. Charlton held various accounting positions at Comarco, Inc. from October 2000 to January 2014 culminating in her appointment as Chief Accounting Officer in April 2011. Prior to her 13 year tenure at Comarco, Ms. Charlton held various accounting and finance positions with CKE Restaurants, Inc. from February 1995 to October 2000. Ms. Charlton began her career in July 1991 with KPMG Peat Marwick and was formerly a certified public accountant since 2015.
Age 54
Tenure 9 years
Professional MarksCPA
Address 2361 McGaw Avenue, Irvine, CA, United States, 92614
Phone949 769 3200
Webhttps://www.pro-dex.com

Latest Insider Transactions

2024-11-07Disposed of 1000 shares @ 40.02View
Charlton holds a B.A. in Business Economics from the University of California, Santa Barbara and a CPA license from the California State Board of Accountancy.

Pro Dex Management Efficiency

The company has return on total asset (ROA) of 0.1005 % which means that it generated a profit of $0.1005 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1678 %, meaning that it created $0.1678 on every $100 dollars invested by stockholders. Pro Dex's management efficiency ratios could be used to measure how well Pro Dex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.04 in 2024. Return On Capital Employed is likely to rise to 0.19 in 2024. At this time, Pro Dex's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 16.7 M in 2024, whereas Intangible Assets are likely to drop slightly above 51.3 K in 2024.
Pro Dex currently holds 13.55 M in liabilities with Debt to Equity (D/E) ratio of 0.67, which is about average as compared to similar companies. Pro Dex has a current ratio of 2.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Pro Dex's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 4 records

CFO Age

Barry SteeleInfuSystems Holdings
53
Peter HackelStraumann Holding AG
54
Barry CPAInfuSystems Holdings
53
Joseph PellegrinoLeMaitre Vascular
59
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. Pro Dex (PDEX) is traded on NASDAQ Exchange in USA. It is located in 2361 McGaw Avenue, Irvine, CA, United States, 92614 and employs 146 people. Pro Dex is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Pro Dex Management Team

Elected by the shareholders, the Pro Dex's board of directors comprises two types of representatives: Pro Dex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Dex's management team and ensure that shareholders' interests are well served. Pro Dex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Dex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Chris Jackson, Directors Operations
Richard Kirk, CEO and President COO, Director and Member of Investment Committee
Alisha Charlton, CFO Secretary

Pro Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pro Dex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pro Stock Analysis

When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.